In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Clinical Decision Making Toolkit

One of the best tools to help practitioners make the best bedside clinical decisions when managing patients with acute cardiovascular diseases.

See more
Be Guidelines Smart

A comprehensive guidelines implementation toolkit especially for Nurses & Allied Professionals. 

See more

Cardio Protective drugs

 

Antiplatelets

Antiplatelet therapy in ischemic heart disease

See more

 

ACE inhibitors & ARBs

ACE inhibitors & ARBs, a cornerstone in the prevention & treatment of cardiovascular disease.

See more

 

Beta-blockers

Modes of action and cardiovascular effects, indications, contraindications and side effects.

See more

 

Statins & more

Overview of common lipid-lowering drugs used in secondary prevention to reach LDL treatment goals.

See more

 

Polypills

The use of polypills in cardiovascular disease patients.

See more


The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer, and Sanofi and Regeneron in the form of educational grants.